El-Far Amira, Samir Safia, El-Gebaly Eman, Omar Maysa, Dahroug Heba, El-Shenawy Ahmed, Soliman Noha Salah, Gamal Doaa
Microbiology Department, Theodor Bilharz Research Institute (TBRI), Cairo, Egypt.
Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Cairo, Egypt.
Infect Drug Resist. 2021 Nov 19;14:4849-4858. doi: 10.2147/IDR.S335582. eCollection 2021.
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of are the leading cause of healthcare-associated infections worldwide.
The aim was to identify the resistant phenotypes among and to characterize different aminoglycosides and carbapenem resistance genes as major mechanisms of resistance in these isolates, in Theodor Bilharz Research Institute (TBRI), a tertiary care hospital in Cairo, Egypt.
During a period of 11 months, 42 clinical isolates were collected from the microbiology laboratory by routine culture. Antimicrobial sensitivity testing to the aminoglycosides gentamicin and amikacin, and other classes of antibiotics, was performed by a disk diffusion method. Isolates were tested for aminoglycoside resistance genes, , , , , , , and , and carbapenemase resistance genes , , and , using conventional PCR.
Thirty-three (78.5%) of the clinical isolates showed MDR and XDR phenotypes at 42.4% and 57.65%, respectively, and these were included in the study. Aminoglycoside resistance was found in 97%, whereas carbapenem resistance was found in 81% of the isolates phenotypically. Only 59.4% (19/26) of the aminoglycoside-resistant isolates harbored resistance genes; none of the amikacin-susceptible isolates harbored any of the tested aminoglycoside resistance genes. Aminoglycoside resistance genes , , , and were found at rates of 17/33 (51.5%), 3/33 (9%), 2/33 (6%), and 2/33 (6%), respectively, whereas , , and were not detected. Only 40.7% (11/27) of the carbapenem-resistant isolates harbored resistance genes. Carbapenem resistance genes, and , were found at rates of 7/33 (21.2%) and 6/33 (18.1%), respectively, and was not detected.
Rates of MDR and XDR and resistance to aminoglycosides and carbapenems in our setting are high. Methyltransferases and metallo-beta-lactamases are the main mechanisms of resistance to aminoglycosides and carbapenems, respectively. The presence of and in the strains confirms their rapid dissemination in the Egyptian environment.
多重耐药(MDR)和广泛耐药(XDR)菌株是全球医疗保健相关感染的主要原因。
在埃及开罗一家三级护理医院西奥多·比尔哈兹研究所(TBRI),旨在确定菌株中的耐药表型,并将不同的氨基糖苷类和碳青霉烯类耐药基因鉴定为这些分离株耐药的主要机制。
在11个月的时间里,通过常规培养从微生物实验室收集了42株临床分离株。采用纸片扩散法对氨基糖苷类庆大霉素和阿米卡星以及其他类抗生素进行药敏试验。使用常规PCR检测分离株的氨基糖苷类耐药基因、、、、、、、和,以及碳青霉烯酶耐药基因、和。
33株(78.5%)临床分离株分别以42.4%和57.65%的比例表现出MDR和XDR表型,并纳入研究。在表型上,97%的分离株对氨基糖苷类耐药,而81%的分离株对碳青霉烯类耐药。仅59.4%(19/26)的氨基糖苷类耐药分离株携带耐药基因;阿米卡星敏感的分离株均未携带任何检测的氨基糖苷类耐药基因。氨基糖苷类耐药基因、、、和的检出率分别为17/33(51.5%)、3/33(9%)、2/33(6%)和2/33(6%),而、和未检测到。仅40.7%(11/27)的碳青霉烯类耐药分离株携带耐药基因。碳青霉烯类耐药基因和的检出率分别为7/33(21.2%)和6/33(18.1%),未检测到。
我们研究环境中MDR和XDR菌株以及对氨基糖苷类和碳青霉烯类的耐药率很高。甲基转移酶和金属β-内酰胺酶分别是对氨基糖苷类和碳青霉烯类耐药的主要机制。菌株中存在和证实了它们在埃及环境中的快速传播。